Rehabilitation of Patients with Schizophrenia at Different Stages of the Course of the Disease
DOI:
https://doi.org/10.51699/ijhsms.v2i7.2229Abstract
Schizophrenia is characterized by the development of: psychosis (loss of contact with reality), hallucinations (false sensations), delusional states (false beliefs), disorganized speech and behavior, affective dullness (narrowing of the range of emotions), cognitive deficits (impaired logical thinking and problem solving), loss working capacity and social activity. The cause is unknown, but a large role is given to genetic and environmental factors. Symptoms most often develop during adolescence and adolescence.
Downloads
References
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421-427, 2014. doi: 10.1038/nature13595
Correll CU, Rubio JM, Inczedy-Farkas G, et al: Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence. JAMA Psychiatry 74(7):675-684, 2017. doi: 10.1001/jamapsychiatry.2017.0624
Clementz BA, Sweeney JA, Hamm JP, et al: Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 173(4): 373-384, 2016. doi: 10.1176/appi.ajp.2015.14091200
Wang SM, Han C, Lee SJ: Investigational dopamine antagonists for the treatment of schizophrenia. Expert Opin Investig Drugs 26(6):687-698, 2017. doi: 10.1080/13543784.2017.1323870
Фармакотерапия в неврологии и психиатрии: [Пер. с англ.] / Под ред. С. Д. Энна и Дж. Т. Койла. — Москва: ООО: «Медицинское информационное агентство», 2007. — 800 с.: ил. с. — 4000 экз. — ISBN 5-89481-501-0.
В. М. Блейхер, И. В. Крук. Анозогнозия // Толковый словарь психиатрических терминов. — МОДЭК, 1995. — ISBN 5-87224-067-8.
